In the wake of yesterday's Senate hearing on "hidden steroids" sold as dietary supplements, mainstream media outlets are focusing on possible efforts to amend the Dietary Supplement Health and Education Act.
The New York Times notes here that Congress is investigating "whether laws, health agency resources and manufacturing guidelines are adequate to protect the public from products that illegally contain steroids but masquerade as dietary supplements." Meanwhile, the San Francisco Chronicle reports that Sens. Orrin Hatch and Arlen Specter, the only lawmakers present at the hearing, "voiced uncertainty" about the need for changing DSHEA.
McClatchy focuses here on FDA's supposed difficulty in keeping tabs on the dietary supplement market. At the hearing, Michael Levy of the Office of Compliance in the agency's drug center discussed the challenge of identifying and analyzing violative steroid products, but did not request more agency authority over supplements.
Actually, "The Tan Sheet" believes FDA and the Drug Enforcement Administraiton took the most heat from Specter, while the supplement industry was generally spared. The Pennsylvania Democrat, who chairs the Judiciary Subcommittee on Crime and Drugs, once again engaged in the cherished congressional pasttime of bureaucracy bashing.
Continue reading "FDA, DEA Bear Brunt Of Specter's Wrath Over Steroid "Supplements"" »


